Goodwin is representing ARTBIO on the matter. AlphaGen Therapeutics (“AlphaGen”), a biopharmaceutical company, and ARTBIO, Inc., a clinical-stage radiopharmaceutical company developing a new class of targeted...
ARTBIO’s Exclusive Strategic Collaboration with AlphaGen Therapeutics
Myrobalan Therapeutics’ $400,000 Grant from ALS Association
Goodwin advised Myrobalan Therapeutics on the matter. Myrobalan Therapeutics has been granted $400,000 from the ALS Association to support the advancement of its colony-stimulating factor-1 receptor...
Acino’s Acquisition of M8 Pharmaceuticals
Banco J.P. Morgan S.A. is acting as exclusive financial advisor, Goodwin LLP as exclusive legal advisor, and PWC as exclusive accounting and tax advisor to Acino....
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio
Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
SpringWorks Therapeutics’ $300 Million Shares Private Placement
Goodwin Procter advised SpringWorks Therapeutics on the deal. SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced its private placement transaction with a select group of institutional investors to issue...
Palleon Pharmaceuticals’ Collaboration Agreement with Shanghai Henlius Biotech, Inc.
Goodwin Procter advised Palleon Pharmaceuticals on the deal. Palleon Pharmaceuticals announced its strategic collaboration agreement with Shanghai Henlius Biotech, Inc. (2696.HK) to develop and commercialize two bifunctional...
Moderna’s Partnership with Australian Government
Johnson Winter & Slattery worked with Moderna’s US lawyers, Goodwin Procter LLP on the matter. Moderna, a pioneer in mRNA vaccines, signed a 10-year strategic deal with...
Arrakis Therapeutics’ Collaboration Agreement with Amgen
Goodwin Procter advised Arrakis Therapeutics on the deal. Arrakis Therapeutics announced its research collaboration agreement with Amgen (NASDAQ:AMGN), focused on the discovery and development of RNA degrader...
Qilu Pharmaceutical’s Licensing Agreement and Partnership with Arbutus Biopharma Corporation
Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership...